These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27338779)

  • 1. Denosumab, cortical bone and bone erosions in rheumatoid arthritis.
    Rossini M; Adami G; Viapiana O; Idolazzi L; Gatti D
    Ann Rheum Dis; 2016 Oct; 75(10):e70. PubMed ID: 27338779
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to: 'Denosumab, cortical bone and bone erosion in rheumatoid arthritis' by Rossini et al.
    Takeuchi T; Tanaka Y; Ishiguro N; Yamanaka H; Yoneda T; Ohira T; Okubo N; Genant HK; van der Heijde D
    Ann Rheum Dis; 2016 Oct; 75(10):e71. PubMed ID: 27553215
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial.
    Takeuchi T; Tanaka Y; Ishiguro N; Yamanaka H; Yoneda T; Ohira T; Okubo N; Genant HK; van der Heijde D
    Ann Rheum Dis; 2016 Jun; 75(6):983-90. PubMed ID: 26585988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.
    Cohen SB; Dore RK; Lane NE; Ory PA; Peterfy CG; Sharp JT; van der Heijde D; Zhou L; Tsuji W; Newmark R;
    Arthritis Rheum; 2008 May; 58(5):1299-309. PubMed ID: 18438830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repair of Bone Erosion in Rheumatoid Arthritis by Denosumab: A High-Resolution Peripheral Quantitative Computed Tomography Study.
    Yue J; Griffith JF; Xiao F; Shi L; Wang D; Shen J; Wong P; Li EK; Li M; Li TK; Zhu TY; Hung VW; Qin L; Tam LS
    Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1156-1163. PubMed ID: 27768831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis : Denosumab improves bone mineral density in osteoporosis with rheumatoid arthritis.
    Nakamura Y; Suzuki T; Kato H
    Arch Osteoporos; 2017 Sep; 12(1):80. PubMed ID: 28936606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab update.
    Lewiecki EM
    Curr Opin Rheumatol; 2009 Jul; 21(4):369-73. PubMed ID: 19424068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separately tackling the development of erosions with denosumab: ultimately closing a gap in the treatment of patients with rheumatoid arthritis or trying too hard too late?
    Verschueren P; Westhovens R
    Ann Rheum Dis; 2016 Jun; 75(6):947-9. PubMed ID: 26861701
    [No Abstract]   [Full Text] [Related]  

  • 9. Denosumab for bone diseases: translating bone biology into targeted therapy.
    Tsourdi E; Rachner TD; Rauner M; Hamann C; Hofbauer LC
    Eur J Endocrinol; 2011 Dec; 165(6):833-40. PubMed ID: 21852390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-cost, low-field dedicated extremity magnetic resonance imaging in early rheumatoid arthritis: a 1-year follow-up study.
    Lindegaard HM; Vallø J; Hørslev-Petersen K; Junker P; Østergaard M
    Ann Rheum Dis; 2006 Sep; 65(9):1208-12. PubMed ID: 16540550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of denosumab and bisphosphonates for treating secondary osteoporosis in patients with rheumatoid arthritis.
    Kinoshita H; Miyakoshi N; Kashiwagura T; Kasukawa Y; Sugimura Y; Shimada Y
    Mod Rheumatol; 2017 Jul; 27(4):582-586. PubMed ID: 27659808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients.
    Deodhar A; Dore RK; Mandel D; Schechtman J; Shergy W; Trapp R; Ory PA; Peterfy CG; Fuerst T; Wang H; Zhou L; Tsuji W; Newmark R
    Arthritis Care Res (Hoboken); 2010 Apr; 62(4):569-74. PubMed ID: 20391513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis.
    Nakamura Y; Suzuki T; Yoshida T; Yamazaki H; Kato H
    Nutrients; 2017 Apr; 9(5):. PubMed ID: 28445420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis in rheumatoid arthritis.
    Dequeker J; Maenaut K; Verwilghen J; Westhovens R
    Clin Exp Rheumatol; 1995; 13 Suppl 12():S21-6. PubMed ID: 8846540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Denosumab, the rheumatologist's joker?].
    Bérengère AR
    Rev Med Suisse; 2009 Jan; 5(185):59-62. PubMed ID: 19216327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of denosumab treatment on bone mineral density and joint destruction in patients with rheumatoid arthritis.
    Mochizuki T; Yano K; Ikari K; Kawakami K; Hiroshima R; Koenuma N; Ishibashi M; Momohara S
    J Bone Miner Metab; 2018 Jul; 36(4):431-438. PubMed ID: 28681148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoid of bone resembling rheumatoid arthritis; report of a case.
    BUCHMANN M; JOLES S; NELKEN L
    Acta Med Orient; 1953 Mar; 12(3):80-6. PubMed ID: 13050335
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of bone edema with the progression of bone erosions quantified by hand magnetic resonance imaging in patients with rheumatoid arthritis in remission.
    Lisbona MP; Pàmies A; Ares J; Almirall M; Navallas M; Solano A; Maymó J
    J Rheumatol; 2014 Aug; 41(8):1623-9. PubMed ID: 24986851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Distal Radius Bone Mineral Density in Osteoporosis Patients Receiving Denosumab, Including Those with Rheumatoid Arthritis and Those Receiving Oral Glucocorticoids.
    Matsuno H
    Drugs R D; 2016 Dec; 16(4):347-353. PubMed ID: 27766589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANKL: A therapeutic target for bone destruction in rheumatoid arthritis.
    Tanaka S; Tanaka Y; Ishiguro N; Yamanaka H; Takeuchi T
    Mod Rheumatol; 2018 Jan; 28(1):9-16. PubMed ID: 28880683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.